Inorganic Polyphosphate Promotes Colorectal Cancer Growth via TRPM8 Receptor Signaling Pathway

• Published in: Cancers Vol. 16; no. 19; p. 3326
• Main Authors: Arrè, Valentina, Balestra, Francesco, Scialpi, Rosanna, Dituri, Francesco, Donghia, Rossella, Coletta, Sergio, Stabile, Dolores, Bianco, Antonia, Vincenti, Leonardo, Fedele, Salvatore, Shen, Chen, Pettinato, Giuseppe, Scavo, Maria Principia, Giannelli, Gianluigi, Negro, Roberto
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 28-09-2024; MDPI
• Subjects: Biomarkers; Biopsy; Blood coagulation; Calcium channels; Calcium signalling; Cancer; Carcinogenesis; Cell cycle; Cell growth; Cell proliferation; Cell size; Colorectal cancer; Colorectal carcinoma; Cyclin B; Energy metabolism; Ethylenediaminetetraacetic acid; Growth; Kinases; Mammalian cells; Mutation; Oncology, Experimental; Organoids; Orthophosphate; Photographic industry; Proteins; RNA-mediated interference; Scientific equipment and supplies industry; Signal transduction; Surgery; Transient receptor potential proteins; Tumors; United Kingdom; California; United States; Massachusetts; Japan; Missouri; United States > US; colorectal cancer; inorganic polyphosphate; proliferation; ccnb1; TRPM8 receptor; organoids
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers16193326

Colorectal cancer (CRC) is characterized by a pro-inflammatory microenvironment and features high-energy-supply molecules that assure tumor growth. A still less studied macromolecule is inorganic polyphosphate (iPolyP), a high-energy linear polymer that is ubiquitous in all forms of life. Made up of hundreds of repeated orthophosphate units, iPolyP is essential for a wide variety of functions in mammalian cells, including the regulation of proliferative signaling pathways. Some evidence has suggested its involvement in carcinogenesis, although more studies need to be pursued. Moreover, iPolyP regulates several homeostatic processes in animals, spanning from energy metabolism to blood coagulation and tissue regeneration.
In this study, we tested the role of iPolyP on CRC proliferation, using in vitro and ex vivo approaches, in order to evaluate its effect on tumor growth. We found that iPolyP is significantly increased in tumor tissues, derived from affected individuals enrolled in this study, compared to the corresponding peritumoral counterparts. In addition, iPolyP signaling occurs through the TRPM8 receptor, a well-characterized Na
and Ca
ion channel often overexpressed in CRC and linked with poor prognosis, thus promoting CRC cell proliferation. The pharmacological inhibition of TRPM8 or RNA interference experiments performed in established CRC cell lines, such as Caco-2 and SW620, showed that the involvement of TRPM8 is essential, greater than that of the other two known iPolyP receptors, P2Y1 and RAGE. The presence of iPolyP drives cancer cells towards the mitotic phase of the cell cycle by enhancing the expression of
, which encodes the Cyclin B protein. In vitro 2D and 3D data reflected the ex vivo results, obtained by the generation of CRC-derived organoids, which increased in size.
These results indicate that iPolyP may be considered a novel and unexpected early biomarker supporting colorectal cancer cell proliferation.